Yes, a shareholder pointed that out to me last week.
On a whim, I sent an e-mail to David Esposito at his old website, hoping that perhaps he would reply. I asked him if this new appointment would detract from his interest and/or involvement in Medizone.
To my surprise, he did answer, briefly but cordially, and said clearly that he remains committed to working to market AsepticSure to realize its full potential. If anything, he views the new connection as a potential benefit to Medizone, by creating new relationships in the medical industry. He was businesslike but cordial, and I have no reason to doubt his sincerity.
I think the reason that many might view the news of his new affiliation as a blow to MZEI, is because we (including myself) were working under a misunderstanding from the beginning of his joining the BOD a year ago.
It was thought (or hoped) that Esposito's joining the Board was a first step, and he was being groomed to take over as CEO. Very likely it was this assumption that fueled the sharp increase in share price last year.
This was never the intention. His becoming part of the BOD was just that, and it was not designed to be anything different. But behind the scenes he has been able to be involved quite a bit. That's what I gather from my sources.